Suppressive effect of dexamethasone on TIMP-1 production involves murine osteoblastic MC3T3-E1 cell apoptosis

Hui Xie1, Ling-Li Tang, Xiang-Hang Luo

  • 1Institute of Endocrinology and Metabolism, Second Xiangya Hospital of Central South University, 139 Middle Renmin Road, Changsha, Hunan, 410011, People's Republic of China.

Amino Acids
|July 25, 2009
PubMed

Insights

High-dose glucocorticoids (GCs) reduce tissue inhibitor of metalloproteinase-1 (TIMP-1) in osteoblasts, increasing apoptosis and contributing to bone loss. TIMP-1 protects osteoblasts from GC-induced cell death independently of MMP inhibition.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Endocrinology

Background:

  • High-dose glucocorticoid (GC) therapy can induce osteoporosis by promoting osteoblast apoptosis.
  • The precise mechanisms underlying GC-induced osteoblast apoptosis remain incompletely understood.
  • Tissue inhibitor of metalloproteinase-1 (TIMP-1), produced by osteoblasts, plays a role in bone metabolism and has shown anti-apoptotic effects in previous studies.

Purpose of the Study:

  • To investigate the effect of dexamethasone (Dex), a GC, on TIMP-1 production in osteoblasts.
  • To determine if Dex-induced changes in TIMP-1 are linked to osteoblast apoptosis.
  • To elucidate the role of TIMP-1's matrix metalloproteinase (MMP)-inhibitory activity in its protective effects against GC-induced apoptosis.

Main Methods:

  • Murine osteoblastic MC3T3-E1 cells were treated with Dex.
  • The impact of Dex on TIMP-1 production was assessed, along with the effects of glucocorticoid receptor (GR) antagonists (RU486, RU40555).
  • Recombinant TIMP-1 protein and siRNA-mediated TIMP-1 knockdown were used to evaluate TIMP-1's role in apoptosis. Mutant TIMP-1 was also employed to assess MMP-independent effects.

Main Results:

  • Dexamethasone significantly decreased TIMP-1 production in MC3T3-E1 cells, an effect blocked by GR antagonists.
  • Recombinant TIMP-1 protein administration reduced caspase-3 activation and Dex-induced apoptosis.
  • TIMP-1 suppression via siRNA exacerbated Dex-induced apoptosis, while MMP-inactive mutant TIMP-1 still protected cells from apoptosis.

Conclusions:

  • Dexamethasone suppresses osteoblast TIMP-1 production via the glucocorticoid receptor pathway.
  • This reduction in TIMP-1 contributes to GC-induced osteoblast apoptosis.
  • The anti-apoptotic function of TIMP-1 in this context is independent of its MMP inhibitory activity, suggesting a direct role in cell survival.

Related Concept Videos